Akadeum Life Sciences Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
35
Akadeum Life Sciences General Information
Description
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
Contact Information
Website
www.akadeum.comCorporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Corporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Akadeum Life Sciences Timeline
Akadeum Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 03-Jun-2025 | $20M | Completed | Generating Revenue | ||
| 12. Accelerator/Incubator | 23-May-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 16-May-2023 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 22-Feb-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 29-Sep-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 11-May-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A1) | 01-Feb-2019 | Completed | Generating Revenue | |||
| 6. Seed Round | 28-Sep-2017 | Completed | Startup | |||
| 5. Seed Round | 31-Jul-2015 | $1M | $1.15M | Completed | Startup | |
| 4. Seed Round | 21-Oct-2014 | $150K | $150K | Completed | Startup |
Akadeum Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed Prime | 5,492,508 | $0.001000 | $0.03 | $0.33 | $0.33 | 1x | $0.33 | 2.59% |
| Seed | 3,627,200 | $0.001000 | $0.02 | $0.29 | $0.29 | 1x | $0.29 | 1.71% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Akadeum Life Sciences Comparisons
Industry
Financing
Details
Akadeum Life Sciences Competitors (21)
One of Akadeum Life Sciences’s 21 competitors is LevitasBio, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LevitasBio | Venture Capital-Backed | Menlo Park, CA | ||||
| Cytena | Formerly VC-backed | Freiburg, Germany | ||||
| FiberCell Systems | Formerly Accelerator/Incubator backed | New Market, MD | ||||
| Macopharma | Corporation | Tourcoing, France | ||||
| StemCell Technologies | Private Debt Financed | Vancouver, Canada |
Akadeum Life Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Akadeum Life Sciences Patents
Akadeum Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240272139-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
| US-12099050-B2 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
| US-20240402150-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Pending | 14-Feb-2023 | ||
| US-20230314428-A1 | Method and system for buoyant-particle-assisted cell therapy | Active | 01-Apr-2022 | ||
| US-12196754-B2 | Method and system for buoyant-particle-assisted cell therapy | Active | 01-Apr-2022 | G01N33/56972 |
Akadeum Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Akadeum Life Sciences Investors (35)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NYBC Ventures | Corporate Venture Capital | Minority | ||
| Innovation Partnerships | Venture Capital | Minority | ||
| Michigan Biomedical Venture Fund | Venture Capital | Minority | ||
| Arboretum Ventures | Venture Capital | Minority | ||
| ArgoPond | Venture Capital | Minority |
Akadeum Life Sciences FAQs
-
When was Akadeum Life Sciences founded?
Akadeum Life Sciences was founded in 2014.
-
Where is Akadeum Life Sciences headquartered?
Akadeum Life Sciences is headquartered in Ann Arbor, MI.
-
What is the size of Akadeum Life Sciences?
Akadeum Life Sciences has 24 total employees.
-
What industry is Akadeum Life Sciences in?
Akadeum Life Sciences’s primary industry is Biotechnology.
-
Is Akadeum Life Sciences a private or public company?
Akadeum Life Sciences is a Private company.
-
What is Akadeum Life Sciences’s current revenue?
The current revenue for Akadeum Life Sciences is .
-
How much funding has Akadeum Life Sciences raised over time?
Akadeum Life Sciences has raised $55.4M.
-
Who are Akadeum Life Sciences’s investors?
NYBC Ventures, Innovation Partnerships, Michigan Biomedical Venture Fund, Arboretum Ventures, and ArgoPond are 5 of 35 investors who have invested in Akadeum Life Sciences.
-
Who are Akadeum Life Sciences’s competitors?
LevitasBio, Cytena, FiberCell Systems, Macopharma, and StemCell Technologies are some of the 21 competitors of Akadeum Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
